1. Home
  2. HEI vs RVMD Comparison

HEI vs RVMD Comparison

Compare HEI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heico Corporation

HEI

Heico Corporation

HOLD

Current Price

$298.75

Market Cap

41.7B

Sector

Industrials

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$188.42

Market Cap

40.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HEI
RVMD
Founded
1957
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.7B
40.3B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
HEI
RVMD
Price
$298.75
$188.42
Analyst Decision
Buy
Strong Buy
Analyst Count
24
25
Target Price
★ $390.70
$257.80
AVG Volume (30 Days)
412.2K
★ 2.1M
Earning Date
08-25-2026
11-04-2026
Dividend Yield
★ 0.09%
N/A
EPS Growth
★ 33.51
N/A
EPS
★ 4.67
N/A
Revenue
★ $4,485,044,000.00
N/A
Revenue This Year
$20.55
N/A
Revenue Next Year
$11.39
$558.43
P/E Ratio
$64.25
★ N/A
Revenue Growth
★ 16.26
N/A
52 Week Low
$256.11
$55.40
52 Week High
$376.86
$224.31

Technical Indicators

Market Signals
Indicator
HEI
RVMD
Relative Strength Index (RSI) 40.88 44.61
Support Level $292.63 $188.18
Resistance Level $301.10 $194.19
Average True Range (ATR) 7.42 10.41
MACD 1.02 -0.21
Stochastic Oscillator 43.01 37.97

Price Performance

Historical Comparison
HEI
RVMD

About HEI Heico Corporation

Heico is an aerospace and defense supplier that focuses on creating replacement parts for commercial aircraft and components for defense products. In commercial aerospace, Heico is the largest independent producer of replacement aircraft parts. In the defense market, the company produces niche subcomponents used in targeting technology as well as simulation equipment, among other categories. It operates two segments: the flight support group and the electronic technologies group. Both supply the aerospace and defense sectors to different degrees. Heico is persistently acquisitive, focusing on companies in similar or adjacent markets that offer strong cash flow and profitable growth potential.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: